Response to "Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy".

Cheng, Yung-Yin; Tsai, Ming-Che; Wei, James Cheng-Chung

Cheng, Yung-Yin; Tsai, Ming-Che; Wei, James Cheng-Chung.

Cheng YY; Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan.
Tsai MC; Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan.
Wei JC; Department of Emergency Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.

Am J Gastroenterol ; 116(12): 2474, 2021 12 01.

Article in English | MEDLINE | ID: covidwho-1377130

Subject(s)

COVID-19; Proton Pump Inhibitors; Angiotensin-Converting Enzyme 2; Humans; Proton Pump Inhibitors/adverse effects; Risk Factors; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Proton Pump Inhibitors / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Gastroenterol Year: 2021 Document Type: Article Affiliation country: Ajg.0000000000001495

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google